Research location
Kawachi-Nagano
Osaka, Japan
Advertisement
Research activity in Kawachi-Nagano
Osaka, JapanCureCurrent currently publishes aggregate city-level research activity for this location: 16 trials and 16 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Kawachi-Nagano
16 linked trials · page 1 of 1A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaNCT06977581 · 2025-05-20 · 1 site observation
RECRUITING
A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid ArthritisNCT06073093 · 2023-11-07 · 1 site observation
COMPLETED
Dose-range Finding Efficacy and Safety Study for QBW251 in COPD PatientsNCT04072887 · 2019-09-12 · 1 site observation
COMPLETED
A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to BiologicsNCT02960490 · 2016-11-26 · 1 site observation
COMPLETED
A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to MethotrexateNCT02960438 · 2016-10-20 · 1 site observation
COMPLETED
Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid ArthritisNCT02638948 · 2016-02-16 · 1 site observation
COMPLETED
Effects of Abatacept in Patients With Early Rheumatoid ArthritisNCT02504268 · 2015-09-03 · 1 site observation
COMPLETED
A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDsNCT02308163 · 2014-08-08 · 1 site observation
COMPLETED
A Study to Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) TreatmentNCT02305849 · 2014-07-25 · 1 site observation
COMPLETED
Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.NCT01770379 · 2012-10-01 · 1 site observation
TERMINATED
A Study to Continue ASP015K Treatment to Rheumatoid Arthritis Patients Who Completed Phase IIb Study or Phase III Study of ASP015KNCT01638013 · 2012-06-13 · 1 site observation
COMPLETED
Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα AgentsNCT01377012 · 2011-08-30 · 1 site observation
COMPLETED
Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-NCT01129596 · 2010-06-10 · 1 site observation
COMPLETED
Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In JapanNCT00687193 · 2009-03-01 · 1 site observation
COMPLETED
Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In JapanNCT00661661 · 2008-04-01 · 1 site observation
COMPLETED
Comparison Of 4 CP-690,550 Doses Vs. Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis in JapanNCT00603512 · 2008-01-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.